News for Cellid, Co., Ltd. (299660.KQ)

Published at

Aug 17, 2022 7:00 PM

by globenewswire.com

mixed

mixed

Global Human Papillomavirus Associated Cancer Pipeline Insight | Clinical Trials Research Report 2022 by DelveInsight

Human Papillomavirus Associated Cancer Pipeline constitutes 50+ key companies continuously working towards developing 50+ Human Papillomavirus Associated...

VIRX VACC.OL VACC-ME.OL THTX TH.TO NEXI IOVA GILDD.BA 0JDK.L 095700.KQ RUBY 299660.KQ

Read more →
Published at

Jun 8, 2022 7:00 PM

by globenewswire.com

mixed

mixed

Advanced Cervical Cancer Clinical Trial Pipeline Analysis Research Report 2022 by DelveInsight

As per DelveInsight, recent advances in Cervical Cancer have provided new options for treating patients with advanced forms of the disease, fulfilling a...

XNCR STTK SGEN RCUS RAPT NGM IOVA INCY I1NC34.SA CRVS BCAB AGEN 600276.SS 0JDK.L 0J9P.L 0A8R.L NRIX 299660.KQ 095700.KQ

Read more →
Published at

Nov 4, 2021 1:00 AM

by globenewswire.com

mixed

mixed

Cervical Cancer Pipeline Offers Promising New Options for Treatment | DelveInsight

The current chemotherapy-dominated landscape of cervical cancer treatment is set to change to include multiple different drug classes. ...

299660.KQ MGNX IOVA GNMSF GMABN.MX GMAB EXEL ADXS 0JDK.L XNCR VACC.OL VACC-ME.OL SGEN RUBY REGN FATE AZN 9926.HK 0A8R.L 095700.KQ

Read more →